Diagnostic Center | April 16, 2024
Novartis reports data from trial of IgA nephropathy treatment
IgAN is a heterogeneous, progressive, rare kidney disease and is a major cause of chronic kidney disease worldwide
IgAN is a heterogeneous, progressive, rare kidney disease and is a major cause of chronic kidney disease worldwide
Sputnik Light as a booster significantly increases virus neutralizing activity against Omicron based on sera 2-3 months after revaccination
Sputnik Light has been authorised in more than 15 countries with the registration process ongoing in a further 30 countries
Sputnik Light is the first component (recombinant human adenovirus serotype number 26 (rAd26)) of Sputnik
AstraZeneca, Sinopharm and Moderna were part of the study
Subscribe To Our Newsletter & Stay Updated
